Antibody-based therapies for infectious diseases: renaissance for an abandoned arsenal?

被引：4

作者：

Casadevall, A

Goldman, DL

Feldmesser, M

机构：

[1] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10461 USA

[2] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol, Bronx, NY 10461 USA

[3] Yeshiva Univ Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA

来源：

BULLETIN DE L INSTITUT PASTEUR | 1997年 / 95卷 / 04期

关键词：

therapeutics; immunoglobulin; opportunistic infection; HIV; RSV; antibiotic; resistance; septic shock; review;

D O I：

10.1016/S0020-2452(97)83532-5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest, Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.

引用

页码：247 / 257

页数：11

共 50 条

[1] THE CYTOPLASMIC TAIL OF CD4 IS REQUIRED FOR INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION BY ANTIBODIES THAT BIND TO THE IMMUNOGLOBULIN CDR3-LIKE REGION IN DOMAIN-1 OF CD4
BENKIRANE, M
SCHMIDANTOMARCHI, H
LITTMAN, DR
HIRN, M
ROSSI, B
DEVAUX, C
[J]. JOURNAL OF VIROLOGY, 1995, 69 (11) : 6904 - 6910
[2] CRYPTIC NATURE OF ENVELOPE V3 REGION EPITOPES PROTECTS PRIMARY MONOCYTOTROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM ANTIBODY NEUTRALIZATION
BOUHABIB, DC
RODERIQUEZ, G
ORAVECZ, T
BERMAN, PW
LUSSO, P
NORCROSS, MA
[J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 6006 - 6013
[3] Crisis in infectious diseases: Time for a new paradigm?
Casadevall, A
[J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 790 - 794
[4] RETURN TO THE PAST - THE CASE FOR ANTIBODY-BASED THERAPIES IN INFECTIOUS-DISEASES
CASADEVALL, A
SCHARFF, MD
[J]. CLINICAL INFECTIOUS DISEASES, 1995, 21 (01) : 150 - 161
[5] SERUM THERAPY REVISITED - ANIMAL-MODELS OF INFECTION AND DEVELOPMENT OF PASSIVE ANTIBODY THERAPY
CASADEVALL, A
SCHARFF, MD
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (08) : 1695 - 1702
[6] NEUTRALIZATION OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES BY THE BROADLY REACTIVE ANTI-V3 MONOCLONAL-ANTIBODY, 447-52D
CONLEY, AJ
GORNY, MK
KESSLER, JA
BOOTS, LJ
OSSORIOCASTRO, M
KOENIG, S
LINEBERGER, DW
EMINI, EA
WILLIAMS, C
ZOLLAPAZNER, S
[J]. JOURNAL OF VIROLOGY, 1994, 68 (11) : 6994 - 7000
[7] PULMONARY HISTOPATHOLOGY INDUCED BY RESPIRATORY SYNCYTIAL VIRUS (RSV) CHALLENGE OF FORMALIN-INACTIVATED RSV-IMMUNIZED BALB/C MICE IS ABROGATED BY DEPLETION OF CD4+ T-CELLS
CONNORS, M
KULKARNI, AB
FIRESTONE, CY
HOLMES, KL
MORSE, HC
SOTNIKOV, AV
MURPHY, BR
[J]. JOURNAL OF VIROLOGY, 1992, 66 (12) : 7444 - 7451
[8] CREWE JE, 1994, P NATL ACAD SCI USA, V91, P1386
[9] PROGNOSTIC FACTORS IN CRYPTOCOCCAL MENINGITIS - STUDY IN 111 CASES
DIAMOND, RD
BENNETT, JE
[J]. ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) : 176 - 181
[10] ANTI-CRYPTOSPORIDIUM-PARVUM ANTIBODIES INHIBIT INFECTIVITY IN-VITRO AND IN-VIVO
DOYLE, PS
CRABB, J
PETERSEN, C
[J]. INFECTION AND IMMUNITY, 1993, 61 (10) : 4079 - 4084

← 1 2 3 4 5 →